TCL Archive Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival July 27, 2012
TCL Archive DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate October 1, 1976
TCL Archive Access to mammography needs improvement, IOM National Cancer Policy Board report finds. June 11, 2004